Roivant Sciences is a biopharmaceutical company that focuses on developing and commercializing innovative therapies. The company was founded in 2014 by Vivek Ramaswamy and is headquartered in New York City. Roivant Sciences is a unique company that operates as a family of independent biopharmaceutical companies, each focused on a specific therapeutic area. The company's mission is to reduce the time and cost of developing new drugs and to bring them to market faster. Roivant Sciences has a diverse pipeline of drug candidates in various stages of development, including treatments for Alzheimer's disease, Parkinson's disease, and schizophrenia.